Related Experiment Video
Updated: Jul 12, 2026

A Novel High-Throughput Ex Vivo Ovine Skin Wound Model for Testing Emerging Antibiotics
Published on: September 16, 2022
FDA Public Workshop Summary: Advancing Animal Models for Antibacterial Drug Development
James M Byrne1,2, Ursula Waack3,2, Edward A Weinstein3
1Office of Infectious Diseases, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA James.Byrne@fda.hhs.gov.
Abstract:
The U.S. Food and Drug Administration (FDA) hosted a public workshop entitled "Advancing Animal Models for Antibacterial Drug Development" on 5 March 2020. The workshop mainly focused on models of pneumonia caused by Pseudomonas aeruginosa and Acinetobacter baumannii The program included discussions from academic investigators, industry, and U.S. government scientists. The potential use of mouse, rabbit, and pig models for antibacterial drug development was presented and discussed.
More Related Videos
06:19Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
Published on: October 11, 2024
05:40Preparation of Agar Bead Embedded Mycobacterium abscessus to Inoculate Immunocompetent Mice Intratracheally
Published on: April 25, 2025
Related Concept Videos
Antibiotic Selection
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Development of Antibiotic Resistance
Production of Antibiotics
Microbiota Modulation by Antibiotics
Clinical Significance of Antibiotic Resistance